Assessing the risk of unsuspected prostate cancer in patients with benign prostatic hypertrophy: a 13-year retrospective study of th...
IS 3-MONTHS PROST-TREATMENT RECIST EVALUATION OF BONE METASTASES BY MRI OF THE AXIAL SKELETON (ASMRI) A SURROGATE ENDPOINT FOR PREDI...
Chimioth茅rapie du cancer prostatique hormonor茅sistant
Traitement du cancer de la prostate : Place de l'hormonothérapie en 2003
Traitement du cancer de la prostate : Nouvelles strat茅gies th茅rapeutiques
Newcastle University ePrints
Denosumab and bone-metastasis-free survival in men with castration-resistant prostate cancer: results of a phase 3, randomised, plac...
Castration-resistant prostate cancer: from new pathophysiology to new treatment targets.
Magnetic resonance imaging of the axial skeleton for detecting bone metastases in patients with high-risk prostate cancer: diagnosti...
Can whole-body magnetic resonance imaging with diffusion-weighted imaging replace Tc 99m bone scanning and computed tomography for s...
